Safety and Efficacy of Cinacalcet in Children Aged Under 3 Years on Maintenance Dialysis
Introduction: Secondary hyperparathyroidism (sHPT) is particularly severe in rapidly growing infants in dialysis. Although cinacalcet is effective and licensed in dialysis in children aged >3 years, its efficacy and safety for children aged <3 years is unknown. Methods: We identified 26 childr...
Saved in:
| Main Authors: | Julie Bernardor, Sacha Flammier, Ilona Zagozdzon, Alexander D. Lalayiannis, Linda Koster-Kamphuis, Enrico Verrina, Eiske Dorresteijn, Isabella Guzzo, Dieter Haffner, Rukshana Shroff, Claus P. Schmitt, Justine Bacchetta |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-07-01
|
| Series: | Kidney International Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924016966 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical observation of Cinacalcet in the treatment of secondary hyperparathyroidism in hemodialysis patients
by: ZHANG Xin, et al.
Published: (2018-01-01) -
A Meta-analysis of Cinacalcet in the treatment of dialysis patients with secondary hyperparathyroidism
by: LV Yuan, et al.
Published: (2018-01-01) -
Using cinacalcet in the treatment of post-transplantation tertiary hyperparathyroidism: a report of two cases
by: Xiang Hua, et al.
Published: (2021-01-01) -
Meta-analysis of cinacalcet plus calcitriol for the treatment of secondary hyperparathyroidism in hemodialysis patients
by: Feng Hui-ling, et al.
Published: (2022-06-01) -
Observation of low dosage of cinacalcet combined with calcitriol injection for the treatment of refractory secondary hyperparathyroidism in hemodialysis patients
by: GUO Jun-li, et al.
Published: (2020-01-01)